Anti-infectives in drug delivery-overcoming the gram-negative bacterial cell envelope

Current Topics in Microbiology and Immunology

Volumn 398, Issue , 2016, Pages 475-496

  Graef, Florian ^a   Gordon, Sarah ^a   Lehr, Claus Michae ^a,b  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; CARDIOLIPIN; DENDRIMER; LIPOSOME; NANOPARTICLE; OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN F; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLGLYCEROL; PHOSPHOLIPID; POLYPEPTIDE ANTIBIOTIC AGENT; PORIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL MEMBRANE; BACTERIAL OUTER MEMBRANE; BACTERIAL STRAIN; BACTERIAL STRUCTURES; BINDING AFFINITY; CELL COMMUNICATION; CELL MEMBRANE PERMEABILITY; CELL STRUCTURE; COMPUTER MODEL; DRUG DELIVERY SYSTEM; ENZYME DEGRADATION; GRAM NEGATIVE BACTERIUM; HUMAN; LIPID BILAYER; MEMBRANE ELECTROPHYSIOLOGY; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; QUORUM SENSING; ANIMAL; CELL WALL; DEVICES; DRUG EFFECTS; GENETICS; METABOLISM; MULTIDRUG RESISTANCE; PROCEDURES;

ANIMALS; ANTI-BACTERIAL AGENTS; CELL WALL; DRUG DELIVERY SYSTEMS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GRAM-NEGATIVE BACTERIA; HUMANS;

EID: 84992582036     PISSN: 0070217X     EISSN: 21969965     Source Type: Book Series    
DOI: 10.1007/82_2016_491     Document Type: Article

References (79)

1. Berglund NA, Piggot TJ, Jefferies D, Sessions RB, Bond PJ, Khalid S (2015) Interaction of the antimicrobial peptide polymyxin B1 with both membranes of E. coli: a molecular dynamics study. PLoS Comput Biol 11:1004180.
2. Cai H, Rose K, Liang LH, Dunham S, Stover C (2009) Development of a liquid chromatography/mass spectrometry-based drug accumulation assay in Pseudomonas aeruginosa. Anal Biochem 385:321-325.
3. Chakraborty SP, Sahu SK, Pramanik P, Roy S (2012) In vitro antimicrobial activity of nanoconjugated vancomycin against drug resistant Staphylococcus aureus. Int J Pharm 436:659-676.
4. Charitat T, Bellet-Amalric E, Fragneto G, Graner F (1999) Adsorbed and free lipid bilayers at the solid-liquid interface. Eur Phys J B 8:583-593.
5. Clifton LA, Johnson CL, Solovyova AS, Callow P, Weiss KL, Ridley H, Le Brun AP, Kinane CJ, Webster JR, Holt SA, Lakey JH (2012) Low resolution structure and dynamics of a colicin-receptor complex determined by neutron scattering. J Biol Chem 287:337-346.
6. Clifton LA, Skoda MW, Le Brun AP, Ciesielski F, Kuzmenko I, Holt SA, Lakey JH (2015) Effect of divalent cation removal on the structure of gram-negative bacterial outer membrane models. Langmuir 31:404-412.
7. Cronin MT, Aptula AO, Dearden JC, Duffy JC, Netzeva TI, Patel H, Rowe PH, Schultz TW, Worth AP, Voutzoulidis K, Schuurmann G (2002) Structure-based classification of antibacterial activity. J Chem Inf Comput Sci 42:869-878.
8. Danelon C, Nestorovich EM, Winterhalter M, Ceccarelli M, Bezrukov SM (2006) Interaction of zwitterionic penicillins with the OmpF channel facilitates their translocation. Biophys J 90:1617-1627.
9. Davin-Regli A, Bolla JM, James CE, Lavigne JP, Chevalier J, Garnotel E, Molitor A, Pages JM (2008) Membrane permeability and regulation of drug “influx and efflux” in enterobacterial pathogens. Curr Drug Targets 9:750-759.
10. Davis TD, Gerry CJ, Tan DS (2014) General platform for systematic quantitative evaluation of small-molecule permeability in bacteria. ACS Chem Biol 9:2535-2544.
11. De E, Basle A, Jaquinod M, Saint N, Mallea M, Molle G, Pages JM (2001) A new mechanism of antibiotic resistance in Enterobacteriaceae induced by a structural modification of the major porin. Mol Microbiol 41:189-198.
12. Der Wissenschaften Akademie, Hamburg Deutsche Akademie, Leopoldina Der Naturforscher (eds) (2013) Antibiotika-Forschung: Probleme und Perspektiven De Gruyter, Berlin.
13. D’Errico G, Silipo A, Mangiapia G, Molinaro A, Paduano L, Lanzetta R (2009) Mesoscopic and microstructural characterization of liposomes formed by the lipooligosaccharide from Salmonella minnesota strain 595 (Re mutant). Phys Chem Chem Phys 11:2314-2322.
14. Dever LA, Dermody TS (1991) Mechanisms of bacterial resistance to antibiotics. Arch Intern Med 5:886-895.
15. Fernandez DI, Le Brun AP, Whitwell TC, Sani MA, James M, Separovic F (2012) The antimicrobial peptide aurein 1.2 disrupts model membranes via the carpet mechanism. Phys Chem Chem Phys 14:15739-15751.
16. Fernandez DI, Le Brun AP, Lee TH, Bansal P, Aguilar MI, James M, Separovic F (2013) Structural effects of the antimicrobial peptide maculatin 1.1 on supported lipid bilayers. Eur Biophys J 42:47-59.
17. Fillion P, Desjardins A, Sayasith K, Lagace J (2001) Encapsulation of DNA in negatively charged liposomes and inhibition of bacterial gene expression with fluid liposome-encapsulated antisense oligonucleotides. Biochim Biophys Acta 1515:44-54.
18. Fischbach MA, Walsh CT (2009) Antibiotics for emerging pathogens. Science 325:1089-1093.
19. Fragneto G, Charitat T, Daillant J (2012) Floating lipid bilayers: models for physics and biology. Eur Biophys J 41:863-874.
20. Gordon YJ, Romanowski EG, McDermott AM (2005) A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs. Curr Eye Res 30:505-515.
21. Gornall JL, Mahendran KR, Pambos OJ, Steinbock LJ, Otto O, Chimerel C, Winterhalter M, Keyser UF (2011) Simple reconstitution of protein pores in nano lipid bilayers. Nano Lett 11:3334-3340.
22. Hajjar E, Mahendran KR, Kumar A, Bessonov A, Petrescu M, Weingart H, Ruggerone P, Winterhalter M, Ceccarelli M (2010) Bridging timescales and length scales: from macroscopic flux to the molecular mechanism of antibiotic diffusion through porins. Biophys J 98:569-575.
23. Hancock RE (1997) Peptide antibiotics. Lancet 349:418-422.
24. Hancock RE, Chapple DS (1999) Peptide antibiotics. Antimicrob Agents Chemother 43: 1317-1323.
25. Huh AJ, Kwon YJ (2011) Nanoantibiotics: a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. J Control Release 156:128-145.
26. Kascakova S, Maigre L, Chevalier J, Refregiers M, Pages JM (2012) Antibiotic transport in resistant bacteria: synchrotron UV fluorescence microscopy to determine antibiotic accumulation with single cell resolution. PLoS ONE 7:e38624.
27. Kreir M, Farre C, Beckler M, George M, Fertig N (2008) Rapid screening of membrane protein activity: electrophysiological analysis of OmpF reconstituted in proteoliposomes. Lab Chip 8:587-595.
28. Kubiak J, Brewer J, Hansen S, Bagatolli LA (2011) Lipid lateral organization on giant unilamellar vesicles containing lipopolysaccharides. Biophys J 100:978-986.
29. Kumar A, Schweizer HP (2005) Bacterial resistance to antibiotics: active efflux and reduced uptake. Adv Drug Deliv Rev 57:1486-1513.
30. Kuzmenko AI, Wu H, McCormack FX (2006) Pulmonary collectins selectively permeabilize model bacterial membranes containing rough lipopolysaccharide. Biochemistry 45:2679-2685.
31. Le Brun AP, Clifton LA, Halbert CE, Lin B, Meron M, Holden PJ, Lakey JH, Holt SA (2013) Structural characterization of a model gram-negative bacterial surface using lipopolysaccharides from rough strains of Escherichia coli. Biomacromolecules 14:2014-2022.
32. Lemmin T, Bovigny C, Lançon D, Dal Peraro M (2013) Cardiolipin models for molecular simulations of bacterial and mitochondrial membranes. J Chem Theory Comput 9:670-678.
33. Lins RD, Straatsma TP (2001) Computer simulation of the rough lipopolysaccharide membrane of Pseudomonas aeruginosa. Biophys J 81:1037-1046.
34. Luckey M, Nikaido H (1980) Specificity of diffusion channels produced by lambda phage receptor protein of Escherichia coli. Proc Natl Acad Sci U S A 77:167-171.
35. Mach T, Chimerel C, Fritz J, Fertig N, Winterhalter M, Futterer C (2008a) Miniaturized planar lipid bilayer: increased stability, low electric noise and fast fluid perfusion. Anal Bioanal Chem 390:841-846.
36. Mach T, Neves P, Spiga E, Weingart H, Winterhalter M, Ruggerone P, Ceccarelli M, Gameiro P (2008b) Facilitated permeation of antibiotics across membrane channels-interaction of the quinolone moxifloxacin with the OmpF channel. J Am Chem Soc 130:13301-13309.
37. Mahendran KR, Hajjar E, Mach T, Lovelle M, Kumar A, Sousa I, Spiga E, Weingart H, Gameiro P, Winterhalter M, Ceccarelli M (2010) Molecular basis of enrofloxacin translocation through OmpF, an outer membrane channel of Escherichia coli-when binding does not imply translocation. J Phys Chem B 114:5170-5179.
38. Mataraci E, Dosler S (2012) In vitro activities of antibiotics and antimicrobial cationic peptides alone and in combination against methicillin-resistant Staphylococcus aureus biofilms. Antimicrob Agents Chemother 56:6366-6371.
39. Mayers D (ed) (2009) Antimicrobial drug resistance: mechanisms of drug resistance. Springer, Berlin.
40. McKenna M (2013) The last resort. Nature 499:394-396.
41. Meng J, Wang H, Hou Z, Chen T, Fu J, Ma X, He G, Xue X, Jia M, Luo X (2009) Novel anion liposome-encapsulated antisense oligonucleotide restores susceptibility of methicillin-resistant Staphylococcus aureus and rescues mice from lethal sepsis by targeting mecA. Antimicrob Agents Chemother 53:2871-2878.
42. Miller MB, Bassler BL (2001) Quorum sensing in bacteria. Annu Rev Microbiol 55:165-199.
43. Modi N, Winterhalter M, Kleinekathofer U (2012) Computational modeling of ion transport through nanopores. Nanoscale 4:6166-6180.
44. Mullineaux CW, Nenninger A, Ray N, Robinson C (2006) Diffusion of green fluorescent protein in three cell environments in Escherichia coli. J Bacteriol 188:3442-3448.
45. Murcia-Soler M, Perez-Gimenez F, Garcia-March FJ, Salabert-Salvador MT, Diaz-Villanueva W, Medina-Casamayor P (2003) Discrimination and selection of new potential antibacterial compounds using simple topological descriptors. J Mol Graph Model 21:375-390.
46. Murcia-Soler M, Perez-Gimenez F, Garcia-March FJ, Salabert-Salvador MT, Diaz-Villanueva W, Castro-Bleda MJ, Villanueva-Pareja A (2004) Artificial neural networks and linear discriminant analysis: a valuable combination in the selection of new antibacterial compounds. J Chem Inf Comput Sci 44:1031-1041.
47. Murzyn K, Rog T, Pasenkiewicz-Gierula M (2005) Phosphatidylethanolamine-phos-phatidylglycerol bilayer as a model of the inner bacterial membrane. Biophys J 88:1091-1103.
48. Nafee N, Husari A, Maurer CK, Lu C, De Rossi C, Steinbach A, Hartmann RW, Lehr CM, Schneider M (2014) Antibiotic-free nanotherapeutics: ultra-small, mucus-penetrating solid lipid nanoparticles enhance the pulmonary delivery and anti-virulence efficacy of novel quorum sensing inhibitors. J Control Release 192:131-140.
49. Naghmouchi K, Le Lay C, Baah J, Drider D (2012) Antibiotic and antimicrobial peptide combinations: synergistic inhibition of Pseudomonas fluorescens and antibiotic-resistant variants. Res Microbiol 163:101-108.
50. Nelson ML, Grier MC, Barbaro SE, Ismail MY (2009) Polyfunctional antibiotics affecting bacterial membrane dynamics. Anti-Infect Agents Med Chem 8:3-16.
51. Nestorovich EM, Danelon C, Winterhalter M, Bezrukov SM (2002) Designed to penetrate: time-resolved interaction of single antibiotic molecules with bacterial pores. Proc Natl Acad Sci U S A 99:9789-9794.
52. Nikaido H, Rosenberg EY (1981) Effect on solute size on diffusion rates through the transmembrane pores of the outer membrane of Escherichia coli. J Gen Physiol 77:121-135.
53. Nikaido H, Rosenberg EY (1983) Porin channels in Escherichia coli: studies with liposomes reconstituted from purified proteins. J Bacteriol 153:241-252.
54. Nuding S, Frasch T, Schaller M, Stange EF, Zabel LT (2014) Synergistic effects of antimicrobial peptides and antibiotics against Clostridium difficile. Antimicrob Agents Chemother 58:5719-5725.
55. O’Shea R, Moser HE (2008) Physicochemical properties of antibacterial compounds: implications for drug discovery. J Med Chem 51:2871-2878.
56. Pages JM, Amaral L (2009) Mechanisms of drug efflux and strategies to combat them: challenging the efflux pump of Gram-negative bacteria. Biochim Biophys Acta 1794:826-833.
57. Pages JM, James CE, Winterhalter M (2008) The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria. Nat Rev Microbiol 6:893-903.
58. Pages JM, Kascakova S, Maigre L, Allam A, Alimi M, Chevalier J, Galardon E, Refregiers M, Artaud I (2013) New peptide-based antimicrobials for tackling drug resistance in bacteria: single-cell fluorescence imaging. ACS Med Chem Lett 4:556-559.
59. Palusinska-Szysz M, Zdybicka-Barabas A, Pawlikowska-Pawlega B, Mak P, Cytrynska M (2012) Anti-Legionella dumoffii activity of Galleria mellonella defensin and apolipophorin III. Int J Mol Sci 13:17048-17064.
60. Pandit KR, Klauda JB (2012) Membrane models of E. coli containing cyclic moieties in the aliphatic lipid chain. Biochim Biophys Acta 1818:1205-1210.
61. Park SC, Park Y, Hahm KS (2011) The role of antimicrobial peptides in preventing multidrug-resistant bacterial infections and biofilm formation. Int J Mol Sci 12:5971-5992.
62. Peetla C, Stine A, Labhasetwar V (2009) Biophysical interactions with model lipid membranes: applications in drug discovery and drug delivery. Mol Pharma 6:1264-1276.
63. Piggot TJ, Holdbrook DA, Khalid S (2011) Electroporation of the E. coli and S. aureus membranes: molecular dynamics simulations of complex bacterial membranes. J Phys Chem B 115:13381-13388.
64. Pornpattananangkul D, Zhang L, Olson S, Aryal S, Obonyo M, Vecchio K, Huang CM, Zhang L (2011) Bacterial toxin-triggered drug release from gold nanoparticle-stabilized liposomes for the treatment of bacterial infection. J Am Chem Soc 133:4132-4139.
65. Renau TE, Leger R, Yen R, She MW, Flamme EM, Sangalang J, Gannon CL, Chamberland S, Lomovskaya O, Lee VJ (2002) Peptidomimetics of efflux pump inhibitors potentiate the activity of levofloxacin in Pseudomonas aeruginosa. Bioorg Med Chem Lett 12:763-766.
66. Ries O, Carnarius C, Steinem C, Ducho C (2015) Membrane-interacting properties of the functionalised fatty acid moiety of muraymycin antibiotics. Med Chem Comm 6:879-886.
67. Rodrigues C, Gameiro P, Prieto M, De Castro B (2003) Interaction of rifampicin and isoniazid with large unilamellar liposomes: spectroscopic location studies. Biochim Biophys Acta 1620:151-159.
68. Silhavy TJ, Kahne D, Walker S (2010) The bacterial cell envelope. Cold Spring Harb Perspect Biol 2:a000414.
69. Singh PR, Ceccarelli M, Lovelle M, Winterhalter M, Mahendran KR (2012) Antibiotic permeation across the OmpF channel: modulation of the affinity site in the presence of magnesium. J Phys Chem B 116:4433-4438.
70. Tenover FC (2006) Mechanisms of antimicrobial resistance in bacteria. Am J Med 119:S3-10.
71. Van Bambeke F, Pages LM, Lee VJ (2010) Inhibitors of bacterial efflux pumps as adjuvants in antibacterial therapy and diagnostoc tools for detection of resistance by efflux. In: Atta-ur-Rahman Choudary MI (ed) Frontiers in anti-infective drug discovery. Bentham, Sharjah.
72. Walsh TJ, Yeldandi V, Mcevoy M, Gonzalez C, Chanock S, Freifeld A, Seibel NI, Whitcomb PO, Jarosinski P, Boswell G, Bekersky I, Alak A, Buell D, Barret J, Wilson W (1998) Safety, tolerance, and pharmacokinetics of a small unilamellar liposomal formulation of amphotericin B (AmBisome) in neutropenic patients. Antimicrob Agents Chemother 42:2391-2398.
73. Wang L, Chen YP, Miller KP, Cash BM, Jones S, Glenn S, Benicewicz BC, Decho AW (2014) Functionalised nanoparticles complexed with antibiotic efficiently kill MRSA and other bacteria. Chem Commun (Camb) 50:12030-12033.
74. Wellington EM, Boxall AB, Cross P, Feil EJ, Gaze WH, Hawkey PM, Johnson-Rollings AS, Jones DL, Lee NM, Otten W, Thomas CM, Williams AP (2013) The role of the natural environment in the emergence of antibiotic resistance in gram-negative bacteria. Lancet Infect Dis 13:155-165.
75. Wu EL, Fleming PJ, Yeom MS, Widmalm G, Klauda JB, Fleming KG, Im W (2014) E. Coli outer membrane and interactions with OmpLA. Biophys J 106:2493-2502.
76. Xiong MH, Bao Y, Yang XZ, Wang YC, Sun B, Wang J (2012) Lipase-sensitive polymeric triple-layered nanogel for “on-demand” drug delivery. J Am Chem Soc 134:4355-4362.
77. Xiong MH, Bao Y, Yang XZ, Zhu YH, Wang J (2014) Delivery of antibiotics with polymeric particles. Adv Drug Deliv Rev 78:63-76.
78. Yount NY, Yeaman MR (2004) Multidimensional signatures in antimicrobial peptides. Proc Natl Acad Sci U S A 101:7363-7368.
79. Zhao W, Rog T, Gurtovenko AA, Vattulainen I, Karttunen M (2008) Role of phosphatidylglycerols in the stability of bacterial membranes. Biochimie 90:930-938.